| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 82.68B | 84.41B | 82.11B | 83.86B | 80.14B | 84.92B |
| Gross Profit | 20.62B | 20.28B | 16.86B | 18.48B | 21.05B | 17.22B |
| EBITDA | 9.71B | 9.76B | 767.00M | 9.61B | 13.76B | 2.43B |
| Net Income | 4.87B | 5.01B | -7.09B | 2.34B | 6.75B | -2.80B |
Balance Sheet | ||||||
| Total Assets | 123.36B | 123.32B | 125.44B | 128.02B | 123.92B | 123.01B |
| Cash, Cash Equivalents and Short-Term Investments | 16.39B | 16.18B | 16.59B | 12.41B | 10.80B | 11.09B |
| Total Debt | 22.98B | 21.92B | 27.04B | 21.64B | 16.96B | 20.44B |
| Total Liabilities | 45.67B | 43.93B | 49.98B | 43.31B | 41.21B | 43.74B |
| Stockholders Equity | 76.64B | 78.29B | 74.39B | 80.49B | 78.85B | 75.80B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.06B | 2.84B | -1.89B | 1.50B | -1.74B |
| Operating Cash Flow | 0.00 | 12.01B | 6.87B | 773.00M | 6.57B | 7.83B |
| Investing Cash Flow | 0.00 | -5.71B | -3.96B | -2.62B | -1.65B | -7.42B |
| Financing Cash Flow | 0.00 | -6.88B | 1.26B | 3.28B | -5.65B | 1.67B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥65.88B | 14.08 | ― | 4.18% | 0.32% | -43.10% | |
74 Outperform | ¥105.60B | 7.58 | ― | 4.71% | 1.16% | 167.89% | |
70 Outperform | ¥49.27B | 9.71 | ― | 4.58% | 0.10% | ― | |
69 Neutral | ¥59.57B | 22.79 | ― | 1.67% | -2.91% | ― | |
66 Neutral | ¥209.98B | 19.24 | ― | 1.24% | -3.06% | 45.21% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
Sakai Chemical Industry Co., Ltd. announced the results of its share buyback program, acquiring 59,000 common shares at a cost of 172,571,300 yen between September 1 and September 30, 2025. This acquisition is part of a broader plan approved by the Board of Directors to repurchase up to 1,000,000 shares, with the intention to cancel all acquired treasury shares, potentially impacting shareholder value and market perception.
The most recent analyst rating on (JP:4078) stock is a Buy with a Yen3146.00 price target. To see the full list of analyst forecasts on Sakai Chemical Industry Co., Ltd. stock, see the JP:4078 Stock Forecast page.
Sakai Chemical Industry Co., Ltd. announced the results of its acquisition of own shares, acquiring 85,800 common shares for 247,649,600 yen between August 1 and August 31, 2025. This acquisition is part of a broader plan resolved in May 2025 to acquire up to 1,000,000 shares, with the company planning to cancel all acquired treasury shares, potentially impacting its stock value and shareholder equity.
The most recent analyst rating on (JP:4078) stock is a Buy with a Yen3146.00 price target. To see the full list of analyst forecasts on Sakai Chemical Industry Co., Ltd. stock, see the JP:4078 Stock Forecast page.
Sakai Chemical Industry Co., Ltd. reported a decline in net sales by 7.9% for the quarter ending June 2025, compared to the previous year. However, the company experienced a significant increase in operating profit by 19.3%, indicating improved operational efficiency. Despite a decrease in profit attributable to owners of the parent by 10%, the company’s ordinary profit rose by 3.6%, reflecting a stable financial position. The capital adequacy ratio slightly decreased from 63.5% to 62.1%, suggesting a minor change in financial leverage.
Sakai Chemical Industry Co., Ltd. announced the results of its acquisition of own shares, acquiring 126,700 common shares for a total of 346,614,500 yen between July 1 and July 31, 2025. This acquisition is part of a larger plan approved by the Board of Directors to acquire up to 1,000,000 shares by November 30, 2025, with the intention to cancel all treasury shares acquired, potentially impacting the company’s share value and market positioning.